Zacks Investment Research
19 May 2026, 14:55 UTC · 2d ago
Source · https://www.zacks.com/stock/news/2923363/wall-street-analysts-believe-candel-therapeutics-cadl-could-rally-148-48-here-s-is-how-to-trade?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|consensus_price_target-2923363
Read source
Search tags
Story key points
2 claims · impact-rated
Wall Street analysts have a mean short-term price target of $19.63 for Candel Therapeutics (CADL), representing a potential 148.5% upside from its last close of $7.9. — A significant gap between current price and analyst consensus typically attracts bullish investor interest and liquidity.
+0.60There is a positive trend in earnings estimate revisions for Candel Therapeutics, with analysts agreeing the company will report better earnings than previously estimated. — Upward revisions in earnings expectations are a strong fundamental signal for future price appreciation.
+0.50Impact vectors
3 dimensions · 9 clusters
Market reaction
0 bid · 0 offered
No stock impact ranking available yet.
No stock impact ranking available yet.
Ticker attribution
Model heads
The company shows strong 4-week gains, a significant consensus price target upside of 148.5%, and positive earnings estimate revisions.
No ticker relationship head found.
